Skip to main content
All blogsLatest News

Why Did Peptide Sciences Shut Down? What to Do Now

If you are searching 'why did Peptide Sciences shut down', the company itself has not answered. Its storefront was replaced in March 2026 by a short notice that calls the closure voluntary and gives no reason. Here is what the notice says, what nobody has confirmed, what to do about an open order, and how the prescription route works for anyone who was buying there.

Medically reviewed by Dr. Cory Mellon, MD13 min read
Published
The company published three paragraphs. Everything beyond them on this page is marked as verified or unknown.
The company published three paragraphs. Everything beyond them on this page is marked as verified or unknown.

Key Takeaways

  • Peptide Sciences' own notice says it 'voluntarily shut down operations' and stopped selling its research products. It gives no date and no reason, and says nothing about open orders. Industry reports put the closure in early March 2026.
  • No FDA warning letter, court action, or regulator statement naming the company turned up in the sources PeRx checked on October 14, 2026. Any article that gives "the real reason" without a company or regulator document is guessing.
  • The company says any site claiming to be its successor, or claiming to sell its products, is unauthorized and fraudulent. Treat relaunch pages, lookalike domains, and leftover-stock offers as unrelated to the company.
  • If you had an open order, the notice offers no refund process. Your card issuer's dispute process is the practical route, and every network's window is limited, so start before it closes.
  • Most of what research sellers carried, including BPC-157, TB-500, CJC-1295/ipamorelin, tesamorelin, GHK-Cu, NAD+ and Semax, is available by prescription through a licensed provider and a state-licensed 503A pharmacy. PeRx does not sell research-use products.

What we know (checked October 14, 2026)

Status

Storefront replaced by a shutdown notice. No catalog, no checkout.

What the notice says

Voluntary shutdown; research products discontinued; trademarks kept and enforced.

What it does not say

A date, a reason, or anything about orders, refunds or support.

Reported closure

Early March 2026 (industry reports). The notice itself is undated.

Enforcement record

No FDA warning letter or court action naming the company found in the sources PeRx checked.

Successor sites

Called 'unauthorized' and 'fraudulent' by the company.

Prescription path

BPC-157, BPC/TB-500, KLOW and others through PeRx: provider-prescribed, 503A pharmacy, no research-use products.

One line before the facts, for readers who already know what they want: PeRx is a provider-prescribed alternative filled by a state-licensed 503A pharmacy. Everything else on this page is about the company that closed, and it is labeled as either verified or unknown.

What Happened to Peptide Sciences? What We Know

Sometime in early March 2026, the Peptide Sciences storefront went offline. The product pages, the downloadable certificates and the checkout were replaced by a single page carrying a short statement. PeRx read that statement again on October 14, 2026. It was unchanged from the wording industry sites quoted in March, and it is still the only thing the company has said in public about the closure.

The notice says the company decided, after careful consideration, to voluntarily shut down operations and discontinue the sale of its research products. It says Peptide Sciences keeps all rights to its name, brand and trademarks, and will continue to protect and enforce them. It thanks customers for their trust. And it says that any website, platform, entity or individual claiming affiliation with the company, representing itself as a successor, or claiming to sell its products is unauthorized and fraudulent, with an email address for reporting that kind of activity. That is the whole of it. Peptide Sciences shut down without giving a reason, and the notice does not mention orders, refunds or a timeline.

The notice carries no date. Industry newsletters and a law-firm commentary published in the second week of March 2026 described the closure as having happened 'in recent days', and several blogs print an exact day and even a time. None of them cites a company source for that precision, so this page does not repeat it. Early March 2026 is as specific as the evidence supports.

The notice in one box

Says: voluntary shutdown, research products discontinued, trademarks retained, successor and reseller claims fraudulent. Does not say: when, why, or what happens to existing orders. Last read by PeRx: October 14, 2026. If the wording changes, this box will be updated with the date of the change.

Is Peptide Sciences Still in Business?

Not as a seller. The company has said it stopped selling its research products, and the site no longer offers a catalog. It has said nothing about its future beyond keeping its trademarks, which is the language of a company that intends to control its name, not necessarily one that plans to reopen. Until the notice changes, treat any page that takes payment under the Peptide Sciences name as unrelated to the company, whatever it says about relaunching. The closure landed in a year of regulatory movement, which PeRx covers separately in the July 2026 FDA peptide review.

Why Did Peptide Sciences Shut Down? What Is and Is Not Confirmed

The company has given one word on the reason: voluntary. That is the entire official explanation. PeRx searched the FDA warning-letter database and ran a general search for enforcement records on October 14, 2026, and found no warning letter, no Department of Justice announcement and no court filing naming Peptide Sciences. That does not prove none exists. It means none is public in the places such records normally appear, and anyone who claims to know otherwise should be able to show you the document.

Two theories circulate online: that payment processors or banks cut the company off, and that enforcement pressure on research-peptide sellers made the business untenable. Neither is confirmed by the company or by any regulator, and PeRx does not repeat them as fact. The second theory at least has a backdrop. A federal judge sentenced a different peptide vendor to prison in July 2026 (what that case changed), and the FDA's advisory committee spent the same month reviewing which peptides compounding pharmacies may use. Pressure on the research lane is real. Whether it is why this company closed is unknown.

A simple test for anything you read about this: if an article gives 'the real reason' and does not link to a statement from the company or a document from a regulator, it is an opinion. The notice is three short paragraphs, and anyone can read it. If the explanation in front of you is longer than that, the extra material came from somewhere else. Whether the wider market is heading the same way is a separate question, covered in will the FDA ban peptides in 2026.

What the Shutdown Means for Research Peptide Buyers

The practical lesson is not about one company. A research-chemical seller can disappear overnight, legally, without owing its customers an explanation, because nothing in the 'research use only' model creates an obligation to the person taking the product. There is no prescriber, no pharmacy license, no patient record and no board to complain to. When Peptide Sciences shut down, every certificate of analysis, every batch number and every support address went with it. Buyers who had been treating that model as a stable supply chain learned in March that it is not one.

The regulatory setting makes a repeat more likely rather than less. The FDA reviewed peptide compounding in public this year, a vendor was sentenced in federal court, and the agency was still issuing warning letters to peptide websites in August 2026 (its letter to Peak Performance Peptides is dated August 24). The guide to whether peptides are legal in 2026 walks through where buyers and sellers each stand. The short version: the legal exposure sits with sellers, and the consequence for buyers is that sellers can vanish.

For readers who were using those products themselves, there is a second question: what to do with the vials you still have. No prescriber can verify what is in them, and no pharmacy will test them for you. How to read a peptide certificate of analysis explains what that paperwork did and did not prove, and is it safe to buy peptides online covers what independent testing of gray-market vials has found.

If You Had an Open Order or Account With Peptide Sciences

Open Orders and Store Credit

The notice says nothing about orders placed before the closure, store credit, loyalty points or customer support, and PeRx cannot speak for the company. If you paid by card and the order never shipped, the useful route is your card issuer's dispute process, not the company's old support address. Call the number on the back of the card, say the merchant closed without delivering, and ask what documentation they want. Every card network sets its own deadline, counted from the charge date, so do not wait for a reply from the company first. No outcome is guaranteed. Payments made by crypto, wire or gift card generally have no dispute route at all.

Sites Using the Peptide Sciences Name

The company's own position is the clearest guide here. It says any site or person claiming affiliation, claiming to be a successor, or claiming to sell its products is unauthorized and fraudulent, and it asks that such activity be reported to it. That covers lookalike domains, relaunch announcements, social accounts offering remaining stock, and discount codes passed around in forums. Treat all of them as unrelated to the company. If you choose to deal with one anyway, avoid any payment method you cannot dispute.

Peptide Sciences Alternative: Research Peptides vs Prescription Peptides

Since Peptide Sciences shut down, the search that has grown fastest is the company's name plus the word 'alternative', and most pages answering it are lists of other research sellers, usually with an affiliate link attached. This page does not rank vendors. It explains the one alternative that does not depend on a storefront staying open: a prescription.

Research Peptides vs Prescription Peptides

'For research use only' means the product is sold as a laboratory chemical. No prescriber has reviewed who is taking it, no pharmacy has dispensed it, and the label says it is not intended for human use. That is a legal position, not a quality grade. It is the absence of any oversight rather than a verdict on the contents, and research peptides vs prescription peptides goes through the four quality differences that follow from it.

A prescription peptide moves through a different system. A licensed provider reviews your history and decides whether the peptide is appropriate for you. A state-licensed 503A compounding pharmacy prepares it for that prescription, tests the batch, and ships it. Compounded peptides are not FDA-approved drugs, and no honest provider will tell you they are. What they have is a prescriber, a licensed pharmacy and a record, which is exactly what the research model lacks.

Which Research Peptides Are Available by Prescription?

The peptides most often bought from research sellers map onto the prescription catalog more completely than most former buyers expect. The table below shows the form each takes at PeRx. Two differences are worth knowing in advance: TB-500 and ipamorelin are prescribed only in combination, and nothing PeRx dispenses is a nasal product.

BPC-157

Notes
Injection ships ready to use; capsules for people who prefer no needle

TB-500

Notes
TB-500 is prescribed at PeRx only in combination with BPC-157

BPC-157, TB-500, GHK-Cu and KPV stacks

Prescription form at PeRx
KLOW
Notes
All four peptides in one ready-to-use vial

CJC-1295 and ipamorelin

Notes
Ipamorelin ships only in combination

Semax, Selank

Notes
PeRx does not carry nasal versions

Thymosin Alpha-1

Notes
The only thymosin PeRx prescribes on its own

Melanotan II, GHRP-6 and other research-only compounds

Prescription form at PeRx
Not prescribed

Questions to Ask Any Peptide Supplier

The vendor-vetting checklists circulating since the closure (a batch-matched certificate from a named lab, a real address, a review history, stable pricing) are useful, and they apply with more force to a prescription provider than to a research seller. Ask these of anyone, including PeRx:

Is the pharmacy licensed, and in which state? A 503A pharmacy is licensed by its state board, and the license number is public. Does a clinician review the patient before anything ships? If the answer is no, you are looking at a research seller with a nicer website. Is each batch tested, and can you see the result? Potency and sterility testing per batch is the floor, not a feature. Are the prices published, and what do they include? Vial, supplies, shipping and provider review should be one number. What happens to your order if the company closes? A prescription belongs to you, the pharmacy keeps a record, and another provider can continue it. The research model has no answer to that last question, which is the point of this page.

PeRx's own answers are on how PeRx tests its peptides and in the peptide comparison. The three products former research buyers ask about most are below.

BPC-157

Recovery

The single most requested peptide from former research buyers. Provider-prescribed, compounded in a US 503A pharmacy, ships ready to use. Capsules available for people who prefer no needle.

BPC-157 at PeRx →

BPC-157/TB-500

Recovery blend

The two peptides research buyers most often stacked, prescribed together in one vial. Also offered as capsules. TB-500 is not available on its own at PeRx.

BPC/TB-500 at PeRx →

KLOW

Four-peptide blend

BPC-157, TB-500, GHK-Cu and KPV in one ready-to-use vial, for people who were mixing a four-part stack themselves. Provider-prescribed, 503A-compounded.

KLOW at PeRx →

Each is provider-prescribed, compounded in a US 503A pharmacy and ships ready to use. The eligibility check takes about a minute and is free.

How to Get Peptides Through a Prescription

The process at PeRx has four steps. You complete a short eligibility check online. A licensed provider reviews your history and any labs you provide, and decides whether to prescribe. If approved, a state-licensed 503A pharmacy fills the prescription and ships it to you in ready-to-use vials, with no mixing or measuring. Before each renewal you complete a check-in with the provider. Nothing is charged until a provider approves the prescription, and PeRx does not sell research-use products.

The detail lives in how to get peptides prescribed online and why peptides require a prescription. For the legal map of the three ways peptides reach US buyers, see where to buy peptides legally; for what is available, the peptide catalog.

Ready to switch to a prescription?

Former research buyers: the eligibility check takes about a minute, and a licensed provider reviews every order before it ships. Already a PeRx patient? Message your care team with any question about switching products.

Frequently Asked Questions About the Peptide Sciences Shutdown

Industry newsletters and a law-firm commentary reported the closure in early March 2026. The notice on the company site is undated, and no company statement gives a day. Blogs that print an exact date and time do not cite a source for it.

The company has not said. Its notice keeps the trademarks and says nothing about reopening. As of October 14, 2026 there is no catalog and no announcement. The company itself says any site claiming to be its successor is unauthorized and fraudulent.

Not according to the company. Its notice says any website or person claiming affiliation, claiming to be a successor, or claiming to sell its products is 'unauthorized, fraudulent, and has no affiliation' with it, and it asks for such sites to be reported.

The notice says nothing about orders or refunds, and PeRx cannot speak for the company. If you paid by card, open a dispute with your card issuer for goods not received. Each network has a deadline counted from the charge date, so do not wait. No outcome is guaranteed.

There is no evidence of that. The company calls the shutdown voluntary, and PeRx found no FDA action naming the company in the warning-letter database or in public records as of October 14, 2026. Enforcement against other peptide websites is real and ongoing, but nothing public connects it to this closure.

Some blogs say it did, in 2023, without linking to a letter. PeRx could not find one addressed to the company on fda.gov as of October 14, 2026. Until someone produces the document, treat the claim as unverified.

No prescriber can verify what is in them, and no pharmacy will test them for you. A certificate of analysis described one batch at one moment, not the vial in your fridge. If you want to continue a peptide, the dependable route is a prescription, where the pharmacy tests the batch it ships to you.

Related Guides

Continue reading about peptides and protocols that pair well with this guide.

References and Review

Statements about Peptide Sciences on this page are limited to the company's own published notice, read and paraphrased by PeRx on October 14, 2026. The enforcement check covered the FDA warning-letter database and a general search of public records on the same date. Medically reviewed by Dr. Cory Mellon, MD. This page will be updated if the notice changes or a primary record appears, and the date of any update will be shown in the byline.

Peptide Sciences. Shutdown notice posted at peptidesciences.com, undated. Read by PeRx on October 14, 2026. View study

U.S. Food and Drug Administration. Warning Letters database, searched for "Peptide Sciences" on October 14, 2026; no letter addressed to the company found. View study

U.S. Food and Drug Administration. Warning letter to Peak Performance Peptides, Phoenix, Arizona, August 24, 2026 (reference 735127). Cited for the general enforcement point only; the letter does not concern Peptide Sciences. View study

Medical Disclaimer

The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.

The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.

The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.

Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.

Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.

© 2026 Wellness MD Group PC DBA PeRx. All rights reserved.